Long-term risk factor management after inpatient cardiac rehabilitation by means of a structured post-care programme

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 6, 2011, Pages 843-849

  Harb, Birgit M ^a   Wonisch, Manfred ^a   Brandt, Dieter ^a   Müller, Rudolf ^b  

^a Pensionsversicherung ^*  (Austria)

^b Pensionsversicherungsanstalt Austria   (Austria)

Author keywords

1 year follow up; Cardiac rehabilitation secondary prevention programme; Coronary heart disease; Health Guide; Risk factors management

Indexed keywords

CHOLESTEROL;

ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART REHABILITATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULSE RATE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TREATMENT OUTCOME;

AGED; AUSTRIA; BLOOD PRESSURE; BODY WEIGHT; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INPATIENTS; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; OBESITY; PILOT PROJECTS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; SMOKING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856849494     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826711398837     Document Type: Article

References (21)

1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burrell G, Cifkova R, et al. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl 2): S1-S113.
2. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update. A scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007; 115: 2675-2682. (Pubitemid 46795281)
3. Bjarnason-Wehrens B, Held K, Hoberg E, Karoff M and Rauch B. Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clin Res Cardiol 2007; (Suppl 2): III/1-III/54.
4. EUROASPIRE I and II Group and European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
5. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554-572.
6. Kotseva K, Wood DA, De Baquer D, Heidrich J and De Backer G, on behalf of the EUROASPIRE II Study Group. Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from the EUROASPIRE II survey. Eur Heart J 2004; (Suppl J): J17-J26.
7. Kotseva K, Wood DA, De Backer G, De Baquer D, Pyorala K and Keil U, on behalf of the EUROASPIRE Study Group. EUROASPIRE III: a survey on lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121-137.
8. Kotseva K, Wood DA, De Backer G, De Baquer D, Pyorala K and Keil U, for the EUROASPIRE III Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929-940.
9. Kotseva K, Wood DA, De Backer G, De Baquer D, Pyorala K and Keil U, for the EUROASPIRE III Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries. EUROASPIRE Study Group. Eur J Cardiovasc Prev Rehabil 2009; 16: 121-137.
10. Bropy JM, Bourgault C and Brassard P. The use of cholesterol-lowering medications after coronary revasculari-zation. CMAJ 2003; 169: 1153-1157. (Pubitemid 37491516)
11. Hofman-Bang C, Lisspers J, Nordlander R, Nygren A, Sundin O, Ohman A, et al. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angio-plasty. A randomized study of a multifactorial program. Eur Heart J 1999; 20: 1465-1474. (Pubitemid 29460016)
12. Kotseva K, Tuniz D, Vernardi G, Molinis G, Valente M, Dorico N, et al. Ambulatory cardiac rehabilitation with individualized care after elective coronary angio-plasty: one year outcome. Eur Heart J 2004; (Suppl J): J37-J46.
13. Pasquali SK, Alexander KP, Coombs LP, Lytle BL and Peterson ED. Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 2003; 145: 445-451. (Pubitemid 36390490)
14. Carlsson R. Serum Cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention program. Scand Cardiovasc J 1998; 50: 1-20. (Pubitemid 28464124)
15. Gutenbrunner C, Schreiber C, Beck K, Walter N, Ehlebracht-Konig I, von Pezold E, et al. Prospektive kon-trollierte Studie uber Langwirksamkeit stationarer Heilverfahren auf das kardiovaskulare Risikoprofil. Phys Rehab Kur Med 2002; 12: 272-283. (Pubitemid 35339400)
16. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and woman with coronary artery diseases. The Stanford Coronary Risk Intervention Project (SCRIPT). Circulation 1999; 89: 975-990. (Pubitemid 24076521)
17. Laimer H. Ein Jahr nach stationarer Rehabilitation-was blieb? J Kardiol 2004; 11: 437-440. (Pubitemid 39486565)
18. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merrit TA, et al. Intensive lifestyle changes for reversal of coronary artery disease. JAMA 1998; 280: 643-647.
19. Willich SN, Muller-Nordhorn J, Kullig J, Binting S, Gohlke H, Hahmann H, et al. for the PIN Study Group. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study. Eur Heart J 2001; 22: 307-313. (Pubitemid 32622459)
20. Voller H, Klein G, Gohlke H, Dovifar C, Bintings S and Willich SN. Sekundarpravention Koronarkranker nach stationarer Rehabilitation (effects of inhospital rehabilitation on cardiovascular risk factors in patients with coronary heart disease). Dtsch med Wochenschrift 2000; 125: 1457-1461.
21. Lear SA, Spinelli JJ, Linden W, Brozic A, Kiess M, Frohlich JJ, et al. The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. AHJ 2006; 152: 334-339.